Target intelligence / Profile preview

Carcinogenic or mutagenic substance (CMR (for "Carcinogenic, Mutagenic, and Reprotoxic"))

Target
CMR (for "Carcinogenic, Mutagenic, and Reprotoxic")
Molecular classification
Other. Includes chemicals, physical agents, sometimes biological agents (like certain viruses)
01

Overview

Carcinogenic and mutagenic molecules are substances capable of causing or promoting the formation of mutations in DNA; such mutations may lead to cancer by disrupting the normal regulation of the cell cycle or fostering genetic instability[1][2][4][6][9]. These substances are commonly regulated under frameworks such as the European CLP Regulation, which categorize agents by the strength of evidence for carcinogenicity and mutagenicity[1][5][7]. Mutagens directly damage genetic material through various mechanisms (chemical adduct formation, chromosomal breaks, aneuploidy, etc.), while carcinogens may act indirectly by accelerating cell division or interfering with DNA repair, and may include physical, chemical, and biological agents (e.g., certain chemicals, radiation, human papilloma virus)[4][9].

Other names
CMR chemicalscarcinogenmutagenclastogenaneugen
02

Mechanism of action

DNA adduct formation and mutagenesis; Induction of chromosomal instability; Disruption of cell cycle regulation; Epigenetic modifications

03

Biological functions

Other. These agents induce DNA damage (mutation), genetic instability, or uncontrolled cell proliferation via assorted mechanisms
04

Disease associations

Cancer (primary)genetic disordersdevelopmental toxicityother chronic diseases
05

Safety considerations

Carcinogenicity (cancer risk)Genotoxicity (heritable genetic damage)Teratogenicity, reproductive toxicityOrgan toxicity (dependent on chemical)

Beyond the preview

Go deeper on Carcinogenic or mutagenic substance (CMR (for "Carcinogenic, Mutagenic, and Reprotoxic")).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carcinogenic or mutagenic substance (CMR (for "Carcinogenic, Mutagenic, and Reprotoxic")).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call